Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, discusses improvements in lung function observed in patients enrolled in the BOREAS trial.

Speakers at the 2024 International Myeloma Society (IMS) conference share the updates from the myeloma space that they were ...

Finerenone showed consistent cardiovascular benefits across heart failure populations, with enhanced efficacy in patients ...

Patients with colorectal cancer (CRC) liver metastases had reduced risk of intrahepatic recurrence when using intraoperative ...

CVS Health is set to lay off 2900 employees nationwide, primarily in corporate roles, as part of a $2 billion cost-saving ...

Investigators from Florida Cancer Specialists & Research Institute explored questions surrounding minimal residual disease ...

April Armstrong, MD, MPH, chief of dermatology, UCLA, discusses the impact of a new oral therapy option for patients with ...

Over the past decade we’ve seen rapid growth in value-based care programs. While some have succeeded in improving quality or ...

The 2024 Trends Shaping the Health Economy report gave a past, present, and future look at diabetes care in the US and the ...

Value-based agreements come with risks and benefits, but a health system’s existing facilities and initiatives can help support the goals associated with them, JT Lew, PharmD, MBA, a managed care ...

Javed Butler, MD, MPH, MBA, discusses the additional benefits of combining finerenone with sodium-glucose cotransporter-2 ...

In less than a month, from August 20 to September 19, amivantamab (Ami; Rybrevant, Johnson & Johnson) received 2 approvals ...